Literature DB >> 20515563

Correlation between thymidylate synthase gene variants, RNA and protein levels in primary colorectal adenocarcinomas.

M H Kristensen1, M Weidinger, M Bzorek, P L Pedersen, J Mejer.   

Abstract

This study was designed to compare thymidylate synthase (TS) genotype, mRNA and protein levels in primary colorectal adenocarcinoma, and to examine the correlation between microsatellite instability (MSI) and TS expression. The TS genotype of 68 patients with colorectal cancer was determined by polymerase chain reaction (PCR) and restriction fragment length polymorphism analysis in peripheral blood mononuclear cells and tumour tissue. The TS mRNA levels in tumour tissue were measured by reverse-transcription PCR, and TS protein levels and MSI status were assessed using immunohistochemistry. Significantly higher mRNA and protein levels were observed in patients with the TS 3R/3R versus the 2R/2R and 2R/3R genotypes. There was no correlation between TS single nucleotide polymorphism and TS expression. Individuals homozygous for the six base-pair insertion in the 3'-untranslated region had significantly higher TS mRNA levels than heterozygous and homozygous wild type individuals. The TS mRNA and protein levels were significantly higher in microsatellite unstable tumours compared with microsatellite stable tumours. There was a significant association between the number of TS enhancer region repeats (in blood) and intratumoural TS mRNA and protein levels. A larger case series investigating the role of TS gene polymorphisms as predictors of sensitivity to 5-fluorouracil-based chemotherapy is required.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20515563     DOI: 10.1177/147323001003800212

Source DB:  PubMed          Journal:  J Int Med Res        ISSN: 0300-0605            Impact factor:   1.671


  7 in total

1.  Pronounced between-subject and circadian variability in thymidylate synthase and dihydropyrimidine dehydrogenase enzyme activity in human volunteers.

Authors:  Bart A W Jacobs; Maarten J Deenen; Dick Pluim; J G Coen van Hasselt; Martin D Krähenbühl; Robin M J M van Geel; Niels de Vries; Hilde Rosing; Didier Meulendijks; Artur M Burylo; Annemieke Cats; Jos H Beijnen; Alwin D R Huitema; Jan H M Schellens
Journal:  Br J Clin Pharmacol       Date:  2016-06-03       Impact factor: 4.335

2.  Influence of TS and ABCB1 gene polymorphisms on survival outcomes of 5‑FU-based chemotherapy in a Chinese population of advanced gastric cancer patients.

Authors:  Jun Chen; Xueming Ying; Ling Zhang; Xiaojun Xiang; Jianping Xiong
Journal:  Wien Klin Wochenschr       Date:  2017-01-10       Impact factor: 1.704

3.  Association between mismatch repair gene and irinotecan-based chemotherapy in metastatic colon cancer.

Authors:  Junli Ma; Yan Zhang; Hong Shen; Linda Kapesa; Wenqiang Liu; Mengsi Zeng; Shan Zeng
Journal:  Tumour Biol       Date:  2015-07-05

4.  Thymidylate synthase O-GlcNAcylation: a molecular mechanism of 5-FU sensitization in colorectal cancer.

Authors:  Ninon Very; Stéphan Hardivillé; Amélie Decourcelle; Julien Thévenet; Madjid Djouina; Adeline Page; Gérard Vergoten; Céline Schulz; Julie Kerr-Conte; Tony Lefebvre; Vanessa Dehennaut; Ikram El Yazidi-Belkoura
Journal:  Oncogene       Date:  2021-11-29       Impact factor: 9.867

5.  Thymidylate synthase gene polymorphism and survival of colorectal cancer patients receiving adjuvant 5-fluorouracil.

Authors:  Violetta Sulzyc-Bielicka; Dariusz Bielicki; Agnieszka Binczak-Kuleta; Mariusz Kaczmarczyk; Wiesława Pioch; Anna Machoy-Mokrzynska; Andrzej Ciechanowicz; Magdalena Gołębiewska; Marek Drozdzik
Journal:  Genet Test Mol Biomarkers       Date:  2013-08-22

6.  ERCC1 C118T associates with response to FOLFOX4 chemotherapy in colorectal cancer patients in Han Chinese.

Authors:  Haina Chai; Jie Pan; Xuelin Zhang; Xiaoyan Zhang; Xiaoying Shen; Hang Li; Kehao Zhang; Changqing Yang; Haihui Sheng; Hengjun Gao
Journal:  Int J Clin Exp Med       Date:  2012-04-06

7.  Analysis of polymorphisms and haplotype structure of the human thymidylate synthase genetic region: a tool for pharmacogenetic studies.

Authors:  Soma Ghosh; M Zulfiquer Hossain; Michael Borges; Michael G Goggins; Roxann G Ingersoll; James R Eshleman; Alison P Klein; Scott E Kern
Journal:  PLoS One       Date:  2012-04-05       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.